[Influence of riboflavin upon the development of dimethylaminoazobenzene (DAB) induced liver cancer in rats].
D000818:Animals; D004357:Drug Synergism; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced* / Q000517:prevention & control; D008297:Male; D009708:Nucleotidases / Q000494:pharmacology; D051381:Rats; D012256:Riboflavin / Q000494:pharmacology*; D013385:Succinate Dehydrogenase / Q000494:pharmacology; D004124:p-Dimethylaminoazobenzene / Q000037:antagonists & inhibitors
D004124:p-Dimethylaminoazobenzene; D013385:Succinate Dehydrogenase; D009708:Nucleotidases; C030287:nucleotidase; D012256:Riboflavin